Genome & Co. (314130) Stock Forecast & Price Target
314130 Analyst Ratings
There are no analyst ratings in the last 3 months.
314130 Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
No analyst ratings match these filters.
Stocks with the Highest Top Analyst Consensus in the General Sector
314130 Financial Forecast
ConsensusKRW -997.08
314130 Earnings Forecast
Next quarter’s earnings estimate for 314130 is -KRW 997.08 with a range of ― to ―. The previous quarter’s EPS was -KRW 997.08. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
ConsensusKRW 6.25B
314130 Sales Forecast
Next quarter’s sales forecast for 314130 is KRW 6.25B with a range of ― to ―. The previous quarter’s sales results were KRW 6.25B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
314130 Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Genome & Co.?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Genome & Co.?
To buy shares of KR:314130, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
